SE7906372L - Heterocykliska foreningar - Google Patents
Heterocykliska foreningarInfo
- Publication number
- SE7906372L SE7906372L SE7906372A SE7906372A SE7906372L SE 7906372 L SE7906372 L SE 7906372L SE 7906372 A SE7906372 A SE 7906372A SE 7906372 A SE7906372 A SE 7906372A SE 7906372 L SE7906372 L SE 7906372L
- Authority
- SE
- Sweden
- Prior art keywords
- alkyl
- hydroxy
- alkoxy
- ring
- zero
- Prior art date
Links
- 125000000623 heterocyclic group Chemical group 0.000 title abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 4
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 3
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 abstract 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract 2
- 125000006559 (C1-C3) alkylamino group Chemical group 0.000 abstract 1
- 125000002723 alicyclic group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 239000003485 histamine H2 receptor antagonist Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- -1 methylenedioxy Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7831153 | 1978-07-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE7906372L true SE7906372L (sv) | 1980-01-28 |
Family
ID=10498669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7906372A SE7906372L (sv) | 1978-07-26 | 1979-07-25 | Heterocykliska foreningar |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4524071A (de) |
| JP (1) | JPS5540670A (de) |
| AU (1) | AU534744B2 (de) |
| BE (1) | BE877889A (de) |
| CH (1) | CH642952A5 (de) |
| DE (1) | DE2928842A1 (de) |
| DK (1) | DK310779A (de) |
| ES (1) | ES482869A1 (de) |
| FR (1) | FR2433527A1 (de) |
| GB (1) | GB2030979B (de) |
| IT (1) | IT1117778B (de) |
| NL (1) | NL7905775A (de) |
| SE (1) | SE7906372L (de) |
| ZA (1) | ZA793443B (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN151188B (de) * | 1978-02-13 | 1983-03-05 | Smith Kline French Lab | |
| US4496567A (en) * | 1978-11-13 | 1985-01-29 | Smith Kline & French Laboratories Limited | Phenyl alkylaminopyrimidones |
| CA1155842A (en) * | 1980-03-29 | 1983-10-25 | Thomas H. Brown | Compounds |
| ZW21281A1 (en) * | 1980-10-01 | 1981-11-18 | Smith Kline French Lab | Amine derivatives |
| US4607107A (en) * | 1980-10-01 | 1986-08-19 | Smith Kline & French Laboratories Ltd. | (4-aminoalkyl-2-pyridyl alkyl)guanidines |
| US4352933A (en) * | 1981-02-06 | 1982-10-05 | Smithkline Beckman Corporation | Chemical methods and intermediates for preparing substituted pyrimidinones |
| US4620001A (en) * | 1981-02-06 | 1986-10-28 | Smithkline Beckman Corporation | Chemical methods and intermediates for preparing substituted pyrimidinones |
| JPS58110681A (ja) * | 1981-12-23 | 1983-07-01 | Showa Denko Kk | 純鉄の錆取り方法 |
| IT1153066B (it) * | 1982-11-18 | 1987-01-14 | Mentedison S P A | Derivati del pirimidin-4-one ad attivita' erbicida |
| PT77623B (en) * | 1982-11-25 | 1986-03-19 | Smith Kline French Lab | Process for the preparation of a small class of histamine h2-antagonists |
| GB8311443D0 (en) * | 1983-04-27 | 1983-06-02 | Smith Kline French Lab | Chemical compounds |
| GB8318638D0 (en) * | 1983-07-09 | 1983-08-10 | Smith Kline French Lab | Chemical compounds |
| GB8320505D0 (en) * | 1983-07-29 | 1983-09-01 | Smith Kline French Lab | Chemical compounds |
| GB8332091D0 (en) * | 1983-12-01 | 1984-01-11 | Smith Kline French Lab | Chemical compounds |
| GB8421427D0 (en) * | 1984-08-23 | 1984-09-26 | Smith Kline French Lab | Chemical compounds |
| JO1410B1 (en) * | 1984-11-03 | 1986-11-30 | سميث كلاين اند فرينش لابوراتوريز ليمتد | Compounds |
| JPS61155373A (ja) * | 1984-12-28 | 1986-07-15 | Yamanouchi Pharmaceut Co Ltd | 新規な２−置換アミノ−４（１ｈ）−ピリミドン誘導体及びその製造法 |
| JPH02101170A (ja) * | 1988-10-07 | 1990-04-12 | Mitsubishi Electric Corp | アルミニウム合金表面の前処理方法 |
| JPH04323392A (ja) * | 1991-04-19 | 1992-11-12 | Nkk Corp | チタン材の酸洗処理方法 |
| US20230349922A1 (en) | 2020-08-11 | 2023-11-02 | Université De Strasbourg | H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1338169A (en) * | 1971-03-09 | 1973-11-21 | Smith Kline French Lab | Ureas thioureas and guanidines |
| GB1419994A (en) * | 1973-05-03 | 1976-01-07 | Smith Kline French Lab | Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them |
| IN146736B (de) * | 1975-10-02 | 1979-08-25 | Smith Kline French Lab | |
| US4145546A (en) * | 1975-10-02 | 1979-03-20 | Smith Kline & French Laboratories Limited | 4-Pyrimidone compounds |
| US4154834A (en) * | 1975-12-29 | 1979-05-15 | Smith Kline & French Laboratories Limited | Substituted isocytosines having histamine H2 -antagonist activity |
| GB1565966A (en) * | 1976-08-04 | 1980-04-23 | Allen & Hanburys Ltd | Aminoalkyl furan derivatives |
| IN151188B (de) * | 1978-02-13 | 1983-03-05 | Smith Kline French Lab |
-
1979
- 1979-07-10 ZA ZA793443A patent/ZA793443B/xx unknown
- 1979-07-17 US US06/058,256 patent/US4524071A/en not_active Expired - Lifetime
- 1979-07-17 DE DE19792928842 patent/DE2928842A1/de not_active Ceased
- 1979-07-23 DK DK310779A patent/DK310779A/da not_active Application Discontinuation
- 1979-07-24 FR FR7919037A patent/FR2433527A1/fr active Granted
- 1979-07-24 IT IT49849/79A patent/IT1117778B/it active
- 1979-07-25 BE BE0/196449A patent/BE877889A/xx not_active IP Right Cessation
- 1979-07-25 JP JP9484379A patent/JPS5540670A/ja active Pending
- 1979-07-25 GB GB7925879A patent/GB2030979B/en not_active Expired
- 1979-07-25 NL NL7905775A patent/NL7905775A/nl not_active Application Discontinuation
- 1979-07-25 CH CH691679A patent/CH642952A5/de not_active IP Right Cessation
- 1979-07-25 SE SE7906372A patent/SE7906372L/xx not_active Application Discontinuation
- 1979-07-26 AU AU49249/79A patent/AU534744B2/en not_active Ceased
- 1979-07-26 ES ES482869A patent/ES482869A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES482869A1 (es) | 1980-09-01 |
| ZA793443B (en) | 1980-12-31 |
| JPS5540670A (en) | 1980-03-22 |
| NL7905775A (nl) | 1980-01-29 |
| DK310779A (da) | 1980-02-29 |
| CH642952A5 (de) | 1984-05-15 |
| FR2433527A1 (fr) | 1980-03-14 |
| IT1117778B (it) | 1986-02-24 |
| AU4924979A (en) | 1980-01-31 |
| GB2030979B (en) | 1983-03-02 |
| IT7949849A0 (it) | 1979-07-24 |
| US4524071A (en) | 1985-06-18 |
| FR2433527B1 (de) | 1982-10-15 |
| DE2928842A1 (de) | 1980-02-14 |
| BE877889A (fr) | 1979-11-16 |
| GB2030979A (en) | 1980-04-16 |
| AU534744B2 (en) | 1984-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE7906372L (sv) | Heterocykliska foreningar | |
| ES476305A1 (es) | Un procedimiento para la preparacion de nuevos derivados aminicos | |
| DE3587568D1 (de) | Diazepine enthaltende pharmazeutische Zusammensetzungen mit Plättchen aktivierender Faktor (PAF)-antagonistischer Wirkung. | |
| DE69331843D1 (de) | Xanthine-Derivate als Antidepressiva | |
| IE780853L (en) | Aminoalkyl thiophene derivatives | |
| ES408565A1 (es) | Procedimiento para la preparacion de diaminas ciclicas di- sustituidas en n, n. | |
| FI823897A0 (fi) | Heterocykliska foereningar | |
| SE8104781L (sv) | Heterocykliska foreningar | |
| SE7610409L (sv) | Farmakologiskt aktiva foreningar | |
| ES8306753A1 (es) | "procedimiento para la preparacion de nuevos derivados de azepina". | |
| NO164351C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkyl-l-fenyl-2-piperazinoalkylpyrazolin-3-on-forbindelser. | |
| PT74199A (de) | Neue trisubstituierte pyrimido<5,4-d>pyrimidine ihre herstel- lung und ihre verwendung als arzneimittel | |
| DE3260518D1 (de) | Nitro-anilines | |
| SE7909507L (sv) | Aminderivat | |
| KR880009964A (ko) | 아릴피페라지닐-에틸(또는 부틸)-페닐-헤테로시클릭 화합물 | |
| SE8303913D0 (sv) | Heterocykliska foreningar | |
| ES527739A0 (es) | Un procedimiento para preparar derivados de pirimidina | |
| SE8406338D0 (sv) | 4,5,6,7-tetrahydrotiazolo/5,4-c/-pyridinderivat | |
| SE8005784L (sv) | Heterocykliska foreningar | |
| NO880143L (no) | Soetemiddel. | |
| ATE58536T1 (de) | 5-aminoalkyl-beta-carbolinderivate, ihre herstellung und verwendung als arzneimittel. | |
| NO914577L (no) | Fremgangsmaate for fremstilling av heterocyklisk substituerte piperazinoalkylbenzoksazin- og -tiazinforbindelser | |
| GB2014561A (en) | Amine derivatives, their preparation and pharmaceutical compositions containing them | |
| SE8301039L (sv) | Heterocykliska derivat | |
| SE8000298L (sv) | Karbamatderivat av merkaptoacylhydroxiproliner |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 7906372-3 |